CODX vs PCAR · rev $3.9M vs P/E 25, rev $33.66B
Co-Diagnostics, Inc. Common Stock (CODX) versus PACCAR Inc (PCAR) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
PACCAR Inc (PCAR) is a farm & heavy construction machinery company listed on NASDAQ.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported PCAR revenue for 2024-12-31 was $33.66B. Net income was $4.16B. Revenue was down 4.2% from 2023-12-31 to 2024-12-31. PCAR currently screens at market cap $61.75B and trailing P/E 25.0.
CODX currently screens at market cap $31.4M. PCAR currently screens at market cap $61.75B and trailing P/E 25.0.
Not investment advice. Open the CODX and PCAR stock pages for the full models.
Not investment advice.